In 2014, shortly after a TKO loss to Michael Bisping in Macau, Cung Le tested positive for elevated levels of Human Growth Hormone (HGH). The UFC promptly handed Le a nine-month suspension, which was later elevated to a twelve-month term. Continue reading →

The report analyzes the leading players of the global USA Human Growth Hormone market by inspecting their market share, recent developments, new product launches, partnerships, mergers, or acquisitions, and their target markets. Continue reading →

LOS ANGELES, United States: QY Research has recently published a report, titled Global Anti-Aging Therapies Market Size, Status and Forecast 2020-2026.The market research report is a brilliant, complete, and much-needed resource for companies, stakeholders, and investors interested in the global Anti-Aging Therapies market. Continue reading →

(Daniel Taylor - Kelowna Capital News) Good morning, Okanagan! Only four more days until the official start of summer. Robert Pershing Wadlow (Feb. 22, 1918 July 15, 1940), also known as the Alton Giant and the Giant of Illinois, was an American man who was the tallest person in recorded history for whom there is irrefutable evidence Continue reading →

By Chris Kocher June 18, 2020 The Thomas J. Watson School of Engineering and Applied Sciences Department of Biomedical Engineering has earned nearly $4 million in grants from 201820 (as of March 2020) Continue reading →

SILVER SPRING, Md., June 18, 2020 /PRNewswire/ -- Today, the U.S. Continue reading →

The report on the Biosimilars/follow-on-biologics market provides a birds eye view of the current proceeding within the Biosimilars/follow-on-biologics market. Further, the report also takes into account the impact of the novel COVID-19 pandemic on the Biosimilars/follow-on-biologics market and offers a clear assessment of the projected market fluctuations during the forecast period. The different factors that are likely to impact the overall dynamics of the Biosimilars/follow-on-biologics market over the forecast period (2019-2029) including the current trends, growth opportunities, restraining factors, and more are discussed in detail in the market study. Continue reading →

Pfizer was the first to release a drug for the treatment of hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) early breast cancer. However, Lilly is expected to make a new treatment history with more substantial clinical data of Verzenio, observers said Continue reading →